Popular searches: AAPL TSLA NVDA MSFT GOOGL

PACB Stock Price Prediction 2026

Pacific Biosciences of California, Inc.

$2.06
$-0.20 (-8.85%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: February 2, 2026

PACB Price Forecast 2026: Our AI models project that PACB stock will rise to approximately $2.42 by 2026. This represents a potential 17.3% growth from the current trading price of $2.06. The overall market sentiment for PACB is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading PACB shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2026 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 46.1, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2026 predicted target.

🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • MACD converging near zero line - potential energy building
  • Volume showing accumulation (CMF: 0.1808)
  • Recent pattern: Doji - Indecision pattern
  • Price near support at $2.15
MACD: Converging | Volume: Accumulation
📈

Volume Trend: Accumulation

Institutional Buying Detected - Smart money is accumulating shares

Chaikin Money Flow (CMF): 0.181
Money Flow Index (MFI): 65.5

Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.

Options Analysis: 1-Year Target Strategy

Score: 69/100

Analysts project the stock to decline. Options analysis identifies premium selling opportunities (covered calls, credit spreads).

SELL PREMIUM - Good covered call opportunity. Analysts bearish with 9.5% downside target.
Wall Street Target
$2.42
-9.5% (below current)
Best Strike Found
$3.00
Exp: Jan. 15, 2027, midnight
Call Premium
$1.00
37.5% of stock price
Breakeven Price
$4.00
⚠ Above target
Implied Probability
59.6%
Market's confidence
Value Score
-100.0
Overpriced
📉
STRONG SELL
Analysts expect stock to decline - Sell calls to collect premium
Seller's Advantage:
Premium Collected
$1.00
Profit if Target Hits
$1.00
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for -9.5% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 2,160 | Volume: 2
Data as of: Jan 23, 2026
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
Based on Wall Street analyst consensus targets
Timeframe Target Price Potential Return
30 Days $2.09 +1.4%
90 Days $2.15 +4.3%
6 Months $2.24 +8.7%
1 Year $2.42 +17.3%

More PACB Analysis

Why is PACB Moving? Buy or Sell PACB? PACB Full Analysis PACB Trendline Analysis
PACB Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$3.02 (+46.8%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$2.42 (+17.5%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$1.69 (-17.8%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
46.1
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
0.18

Key Fundamentals

P/S Ratio (TTM)
4.41x
Fair
Revenue Growth (QoQ)
0.0%
Market Cap
$682M
Analyst Target
$2.42
52-Week High
$2.20
52-Week Low
$2.06

Options Activity

Alert Score
90/100
Classification
Strong Alert
Unusual Activity
80.3
IV Spike
+103.5%

Recommendation: Strong unusual activity detected. Review for potential entry.

Frequently Asked Questions

What is the PACB stock price prediction for 2026?

Based on our AI analysis, PACB is predicted to reach $2.42 by 2026, representing a potential 17.3% increase from the current price of $2.06.

Is PACB stock a good buy right now?

Our analysis suggests PACB is a "BUY" based on current technical and fundamental indicators. With a projected 17.3% upside, investors should consider their risk tolerance and investment horizon.

What is PACB 52-week high and low?

PACB has a 52-week high of $2.20 and a 52-week low of $2.06. The stock is currently trading 6.4% below its 52-week high.

What is the technical analysis for PACB?

PACB is currently in a downtrend trend. The RSI of 46.1 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis